CBDMD, Inc. YCBD announced on Thursday that it will officially sponsor the FIFA-affiliated Costa Rican soccer team, Club Sport Herediano.
The move marks the first and only partnership between a CBD brand and a professional FIFA-recognized premier division soccer team.
"We see this partnership as a major step for the CBD industry towards breaking the stigma of cannabis use in professional sports and, ultimately, setting the stage for partnerships with other teams - both domestically and internationally - in the near future," Ronan Kennedy, cbdMD's interim CEO and CFO said.
Why It Matters
The Charlotte, North Carolina-based company holds the NSF Certified for Sport certification for hemp-derived cannabinoid products and has a lineup that includes its Broad Spectrum CBD Oil Softgels, Broad Spectrum CBD Gummies and CBD PM Softgel Capsules.
The NSF Certified for Sport certification ensures that anyone concerned with drug tests for THC will not fail them, from athletes to first responders, nurses, doctors and anyone else wanting to incorporate CBD into their health and wellness routine without worrying about failing a drug test for THC.
Via the partnership, the medical staff for Club Sport Herediano will be incorporating cbdMD's NSF Certified for Sport products into its players' wellness and recovery routines based on their individual needs.
Alvaro Mora, the physician for Club Sport Herediano explained how athletes would benefit from the new partnership.
"Through the incorporation of cbdMD products into our athletes' nutritional regimen, our aim is to not only minimize the risk of injuries but also expedite recovery should injuries occur," said Mora. "Utilizing products like cbdMD's CBD Freeze will assist us in topically alleviating inflammation and pain related to strenuous activity; similarly, the supplements will further contribute to reducing post-activity inflammation and fatigue, thereby facilitating faster recuperation for our athletes."
YCBD Price Action
cbdMD's shares traded 9.57% higher at $1.03 per share at the time of writing on Thursday morning.
Related News
- cbdMD Reports Q3 2023 Performance: Net Loss Improves, Focus On Cost Management & Strategic Growth
- cbdMD Q2 2023 Results: Net Loss Improves, Costs Plummet
- cbdMD Secures $2.8M Via Underwritten Public Offering Of Common Stock
Photo: Courtesy of Paul Einerhand and Emilio Garcia on Unsplash
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving – don’t get left behind!
Curious about what’s next for the industry and how to leverage California’s unique market?
Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!
Get your tickets now to secure your spot and avoid last-minute price hikes.